Not independent
Tenure on this board
14.4 yrs
Also a director at
Aclarion Inc (ACON)
4 nominees · 2 ballot items.
Two management proposals: (1) grant the board authority to effect a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-200 within one year if the board elects to do so, and (2) authorize the board to adjourn the Special Meeting to a later date to solicit additional proxies if necessary; the board unanimously recommends voting FOR both proposals.
Authorize the board to amend the Certificate of Incorporation to combine outstanding shares of common stock into a lesser number of shares (a reverse stock split) at a ratio the board selects within a range of one-for-two (1-for-2) to one-for-two hundred (1-for-200), and to effect such reverse split, if at all, within one year of stockholder approval, with the board able to abandon the amendment.
This management proposal asks shareholders to grant the board discretionary authority to amend the Certificate of Incorporation and effect a reverse stock split at a ratio the board selects within a wide range (1-for-2 up to 1-for-200) within one year of approval. Management is seeking this authority primarily to increase the per-share trading price to help the Company regain or maintain compliance with Nasdaq’s $1.00 minimum bid price requirement and to make the stock more attractive to institutional and professional investors. The board points to prior notices from Nasdaq and a prior March 2025 reverse split as context for the continuing risk of non-compliance and the need for flexibility. By allowing the board to set the final ratio within the approved range, the board retains the ability to calibrate the split to prevailing market conditions and the Company’s capital needs without requiring another shareholder vote. The proxy also explains that the board may elect not to implement the split even if approved, preserving discretion to abandon the transaction if it judges it would not be in stockholders’ best interests. The proposal acknowledges potential downsides: adverse market perception of reverse splits, possible post-split share price declines, potential liquidity reduction, and the administrative/accounting and tax consequences of a recapitalization. The filing warns that the split would increase the number of authorized but unissued shares (because outstanding shares would be reduced without changing authorized shares), which could increase the Board’s ability to issue additional shares in the future—an aspect investors should weigh as a potential source of dilution. The board’s unanimous recommendation “FOR” is grounded on restoring compliance, improving investor access, and preserving financing flexibility while retaining the ability to abandon the split if conditions are unfavorable.
Authorize the proxies and the board to adjourn the Special Meeting to a later date or dates, if necessary, to permit additional solicitation and voting of proxies to obtain approval of the Reverse Stock Split proposal or to establish a quorum.
This management proposal seeks shareholder approval to permit the board and its proxies to adjourn the Special Meeting to another time or place to continue soliciting proxies if there are insufficient votes or a lack of quorum to approve Proposal 1. The request is procedural in purpose but strategic in effect: it gives the Company the ability to extend the solicitation period and attempt to obtain the votes needed to pass the reverse stock split without calling a new meeting. Management frames this as necessary to ensure that stockholder deliberation and voting on the RSS Proposal can continue if initial turnout or voting is insufficient. The proxy statement explains the voting standard (a majority of shares present and entitled to vote) and warns that abstentions count as votes against the adjournment, which shareholders should consider. The board’s unanimous “FOR” recommendation reflects its desire to preserve flexibility to achieve approval of the RSS Proposal and to ensure orderly meeting procedure. While routine in many corporate votes, adjournment authority can also be used tactically to lengthen solicitation and should be evaluated in the context of the underlying substantive proposal (the Reverse Stock Split). The proposal is presented as limited in scope, and the board indicates it would only move to adjourn if necessary to obtain approval or a quorum.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 101,517 | $67K |
| 2 | Tower Research Capital LLC (TRC | 0.1% | 4,869 | $3K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.0% | 1,158 | $766 |
| 4 | MORGAN STANLEY | 0.0% | 77 | $44 |
| 5 | CITIGROUP INC | 0.0% | 1 | $1 |
| 6 | SBI Securities Co., Ltd. | 0.0% | 1 | $1 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.